Accumetrics Closes On $24M In Funding

San Diego-based Accumetrics, a developer of medical devices used to measure antiplatelet therapy, a technique used to prevent heart attack and stroke, said this morning that it has closed on a $24M funding round. The firm said the funding came from existing investors, including Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Rivervest and Kaiser Permanente. Of that funding, $7M was raised recently, with the remainder having been received in the Fall of 2009. The firm said it will use the funding to complete key milestones and expand its global commercialization efforts. Accumetrics sysetm is being used by physicians to measure patient response to antiplatelet therapies, which are prescribed to reduce the occurrence of future heart attacks and strokes. More information »